Figure 5
From: Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker
![Figure 5](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1471-2407-5-47/MediaObjects/12885_2004_Article_235_Fig5_HTML.jpg)
Endogenous expression of EBAG9 in cancer cell lines. Cells were lysed in NP-40 buffer and 50 μg of total protein was separated by SDS-PAGE and analysed by immunoblot using our polyclonal anti-EBAG9 antibody. α-actin served as control indicating protein load.